Lobbying client

NEURELIS, INC.

Biopharmaceutical company specializing in treatments for neurological conditions.

The register keeps a separate record of this client for every firm that files for it and every spelling of its name. All 2 of its records are shown together here.

Filings
11
Filed by
2
Reported in-house
—
Reported by firms
$130,000

Reported lobbying by year

The larger of in-house and firm-reported each year, $ thousands 2024 to 2026

Filings

5 filings for 2026, newest first.
Filing Filed by Amount
3rd Quarter - Report (No Activity)
3rd Quarter 2026
ARNOLD & PORTER KAYE SCHOLER LLP — reported
3rd Quarter - Report
3rd Quarter 2026
FEROX STRATEGIES $40,000 reported
Registration
3rd Quarter 2026
FEROX STRATEGIES — reported
2nd Quarter - Report (No Activity)
2nd Quarter 2026
ARNOLD & PORTER KAYE SCHOLER LLP — reported
1st Quarter - Report
1st Quarter 2026
ARNOLD & PORTER KAYE SCHOLER LLP $10,000 reported

Filed by

Each firm that has reported for this client, and the client itself where it lobbies in-house, with the reports filed and the amounts they disclose.

FirmReportsAmount
ARNOLD & PORTER KAYE SCHOLER LLP 8 $90,000
FEROX STRATEGIES 1 $40,000

Issues lobbied

How many report sections named each issue, counting the current version of each report.

IssueCodeMentions
Health Issues HCR 7
Medicare/Medicaid MMM 2

Bills named in its filings

Bill numbers found in the filers' descriptions, most often named first.

BillCongressTimes named
S. 1214 119th 3
H.R. 7383 119th 3
S. 932 119th 2
H.R. 1262 119th 2
H.R. 7383 118th 1
S. 1214 118th 1

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

Processed by Stripe in a separate window. LegiList never sees card details. Other amounts

From reports filed under the Lobbying Disclosure Act. Firms report what each client paid them; an organisation lobbying for itself reports its own expenses. Amounts count the current version of each report once.